Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies.

Wilkinson MGL, Radziszewska A, Wincup C, Ioannou Y, Isenberg DA, Manson JJ, Jury EC.

Rheumatology (Oxford). 2019 Jul 10. pii: kez252. doi: 10.1093/rheumatology/kez252. [Epub ahead of print]

PMID:
31292651
2.

Diet and lupus: what do the patients think?

Robinson GA, Mcdonnell T, Wincup C, Martin-Gutierrez L, Wilton J, Kalea AZ, Ciurtin C, Pineda-Torra I, Jury EC.

Lupus. 2019 May;28(6):755-763. doi: 10.1177/0961203319845473. Epub 2019 Apr 26.

PMID:
31027464
3.

Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus.

Wincup C, Menon M, Smith E, Schwartz A, Isenberg D, Jury EC, Mauri C; ABIRISK Consortium.

Ann Rheum Dis. 2019 Aug;78(8):1140-1142. doi: 10.1136/annrheumdis-2019-215200. Epub 2019 Mar 28. No abstract available.

4.

Analyzing T-Cell Plasma Membrane Lipids by Flow Cytometry.

Waddington KE, Pineda-Torra I, Jury EC.

Methods Mol Biol. 2019;1951:209-216. doi: 10.1007/978-1-4939-9130-3_16.

PMID:
30825155
5.

Low Percentage of Signal Regulatory Protein α/β+ Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients.

Magill L, Adriani M, Berthou V, Chen K, Gleizes A, Hacein-Bey-Abina S, Hincelin-Mery A, Mariette X, Pallardy M, Spindeldreher S, Szely N, Isenberg DA, Manson JJ, Jury EC, Mauri C.

Front Immunol. 2018 Dec 5;9:2865. doi: 10.3389/fimmu.2018.02865. eCollection 2018.

6.

Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients.

Adriani M, Nytrova P, Mbogning C, Hässler S, Medek K, Jensen PEH, Creeke P, Warnke C, Ingenhoven K, Hemmer B, Sievers C, Lindberg Gasser RL, Fissolo N, Deisenhammer F, Bocskei Z, Mikol V, Fogdell-Hahn A, Kubala Havrdova E, Broët P, Dönnes P, Mauri C, Jury EC; ABIRISK Consortium.

JCI Insight. 2018 Jun 7;3(11). pii: 99274. doi: 10.1172/jci.insight.99274. eCollection 2018 Jun 7.

7.

Transcriptional Regulation of T-Cell Lipid Metabolism: Implications for Plasma Membrane Lipid Rafts and T-Cell Function.

Robinson GA, Waddington KE, Pineda-Torra I, Jury EC.

Front Immunol. 2017 Nov 24;8:1636. doi: 10.3389/fimmu.2017.01636. eCollection 2017. Review.

8.

Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaque.

Smith E, Croca S, Waddington KE, Sofat R, Griffin M, Nicolaides A, Isenberg DA, Torra IP, Rahman A, Jury EC.

Sci Immunol. 2016 Dec 2;1(6). pii: eaah4081. doi: 10.1126/sciimmunol.aah4081.

PMID:
28783690
9.

Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndrome.

Thompson N, Isenberg DA, Jury EC, Ciurtin C.

Rheumatology (Oxford). 2016 Sep;55(9):1548-55. doi: 10.1093/rheumatology/kev420. Epub 2016 Jan 20. Review.

PMID:
26790457
10.

Liver X receptors in immune cell function in humans.

Waddington KE, Jury EC, Pineda-Torra I.

Biochem Soc Trans. 2015 Aug;43(4):752-7. doi: 10.1042/BST20150112. Epub 2015 Aug 3. Review.

PMID:
26551724
11.

Manipulating membrane lipid profiles to restore T-cell function in autoimmunity.

Waddington KE, Jury EC.

Biochem Soc Trans. 2015 Aug;43(4):745-51. doi: 10.1042/BST20150111. Epub 2015 Aug 3.

PMID:
26551723
12.

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium.

Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, C Holland M, H Jensen PE, Jury EC, Kirby H, Kramer D, Lacroix-Desmazes S, Legrand J, Maggi E, Maillère B, Mariette X, Mauri C, Mikol V, Mulleman D, Oldenburg J, Paintaud G, R Pedersen C, Ruperto N, Seitz R, Spindeldreher S, Deisenhammer F; ABIRISK Consortium.

Clin Exp Immunol. 2015 Sep;181(3):385-400. doi: 10.1111/cei.12652. Epub 2015 Jul 2. Review.

13.

Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients.

McDonald G, Deepak S, Miguel L, Hall CJ, Isenberg DA, Magee AI, Butters T, Jury EC.

J Clin Invest. 2014 Feb;124(2):712-24. doi: 10.1172/JCI69571. Epub 2014 Jan 27.

14.

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Nandagudi A, Jury EC, Alonzi D, Butters TD, Hughes S, Isenberg DA.

Lupus. 2013 Sep;22(10):1070-6. doi: 10.1177/0961203313497116. Epub 2013 Jul 17.

15.

Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.

Hofmann SC, Bosma A, Bruckner-Tuderman L, Vukmanovic-Stejic M, Jury EC, Isenberg DA, Mauri C.

J Dermatol Sci. 2013 Jul;71(1):22-8. doi: 10.1016/j.jdermsci.2013.04.012. Epub 2013 Apr 19.

PMID:
23664188
16.

Distinct localization of T cell Agrin during antigen presentation--evidence for the expression of Agrin receptor(s) in antigen-presenting cells.

Kabouridis PS, Pimentel TA, Brancaleone V, D'Acquisto F, Oliani SM, Perretti M, Jury EC.

FEBS J. 2012 Jul;279(13):2368-80. doi: 10.1111/j.1742-4658.2012.08615.x. Epub 2012 May 21.

17.

Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells.

Bosma A, Abdel-Gadir A, Isenberg DA, Jury EC, Mauri C.

Immunity. 2012 Mar 23;36(3):477-90. doi: 10.1016/j.immuni.2012.02.008. Epub 2012 Mar 8.

18.

A negatively charged domain of LAT mediates its interaction with the active form of Lck.

Kabouridis PS, Isenberg DA, Jury EC.

Mol Membr Biol. 2011 Oct-Nov;28(7-8):487-94. doi: 10.3109/09687688.2011.624990.

PMID:
22034845
19.

Primary human CD4+ T cells have diverse levels of membrane lipid order that correlate with their function.

Miguel L, Owen DM, Lim C, Liebig C, Evans J, Magee AI, Jury EC.

J Immunol. 2011 Mar 15;186(6):3505-16. doi: 10.4049/jimmunol.1002980. Epub 2011 Feb 9.

20.

Could the expression of CD86 and FcγRIIB on B cells be functionally related and involved in driving rheumatoid arthritis?

Mauri C, Jury EC.

Arthritis Res Ther. 2010;12(4):133. doi: 10.1186/ar3092. Epub 2010 Aug 13.

21.

New role for Agrin in T cells and its potential importance in immune system regulation.

Jury EC, Kabouridis PS.

Arthritis Res Ther. 2010;12(2):205. doi: 10.1186/ar2957. Epub 2010 Apr 12. Review.

22.

Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus.

Jury EC, Flores-Borja F, Kalsi HS, Lazarus M, Isenberg DA, Mauri C, Ehrenstein MR.

Eur J Immunol. 2010 Feb;40(2):569-78. doi: 10.1002/eji.200939781.

23.

Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis.

Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR.

Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19396-401. doi: 10.1073/pnas.0806855105. Epub 2008 Nov 26.

24.

Lipid rafts and T-lymphocyte function: implications for autoimmunity.

Kabouridis PS, Jury EC.

FEBS Lett. 2008 Nov 12;582(27):3711-8. doi: 10.1016/j.febslet.2008.10.006. Epub 2008 Oct 16. Review.

25.

Agrin signalling contributes to cell activation and is overexpressed in T lymphocytes from lupus patients.

Jury EC, Eldridge J, Isenberg DA, Kabouridis PS.

J Immunol. 2007 Dec 1;179(11):7975-83.

26.

Lipid rafts in T cell signalling and disease.

Jury EC, Flores-Borja F, Kabouridis PS.

Semin Cell Dev Biol. 2007 Oct;18(5):608-15. Epub 2007 Aug 19. Review.

27.
28.
29.

Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus.

Flores-Borja F, Kabouridis PS, Jury EC, Isenberg DA, Mageed RA.

Arthritis Rheum. 2005 Dec;52(12):3955-65.

30.

Statins: immunomodulators for autoimmune rheumatic disease?

Jury EC, Ehrenstein MR.

Lupus. 2005;14(3):192-6. Review.

PMID:
15807195
31.

Statins for atherosclerosis--as good as it gets?

Ehrenstein MR, Jury EC, Mauri C.

N Engl J Med. 2005 Jan 6;352(1):73-5. No abstract available.

PMID:
15635116
32.

Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice.

Lawman S, Mauri C, Jury EC, Cook HT, Ehrenstein MR.

J Immunol. 2004 Dec 15;173(12):7641-6.

33.

Regulation of T-cell receptor signalling by membrane microdomains.

Razzaq TM, Ozegbe P, Jury EC, Sembi P, Blackwell NM, Kabouridis PS.

Immunology. 2004 Dec;113(4):413-26. Review.

34.
35.

Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus.

Jury EC, Kabouridis PS, Flores-Borja F, Mageed RA, Isenberg DA.

J Clin Invest. 2004 Apr;113(8):1176-87.

36.

Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus.

Jury EC, Kabouridis PS, Abba A, Mageed RA, Isenberg DA.

Arthritis Rheum. 2003 May;48(5):1343-54.

37.

Autoantibodies and overlap syndromes in autoimmune rheumatic disease.

Jury EC, D'Cruz D, Morrow WJ.

J Clin Pathol. 2001 May;54(5):340-7. Review.

Supplemental Content

Support Center